Related Experiment Video
Updated: Aug 29, 2026
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Myocardial infarction in a patient with beta-thalassemia major: first report
Zvi G Fridlender1, Deborah Rund
1Department of Medicine, Hadassah University Hospital and the Hebrew University-Hadassah Medical School, Jerusalem, Israel. zvi_f@yahoo.com
Insights
Beta-thalassemia patients are living longer, but face new risks. This case report details a rare myocardial infarction in a beta-thalassemia patient, highlighting potential cardiac complications.
Area of Science:
- Hematology
- Cardiology
- Genetics
Background:
- Thalassemia is a prevalent inherited anemia globally.
- Beta-thalassemia major survival has improved, increasing focus on long-term complications.
- Cardiac issues like heart failure and arrhythmias are leading causes of mortality in these patients.
Observation:
- A case of myocardial infarction with normal coronary arteries is presented.
- The patient was a 48-year-old with beta-thalassemia and no other cardiovascular risk factors.
- Thromboembolic events occur in 4-5% of thalassemia patients.
Findings:
- This is the first reported case of myocardial infarction associated with beta-thalassemia.
- The event occurred despite normal coronary arteries, suggesting non-atherosclerotic mechanisms.
Implications:
- Improved life expectancy in thalassemia necessitates vigilance for ischemic heart disease.
- Further research is needed to understand and manage cardiac risks in thalassemia.
- This case underscores the importance of considering cardiac complications beyond traditional risk factors in thalassemia patients.
Abstract:
Thalassemia is the most common hereditary anemia throughout the world. Survival in its most severe long-term form, beta-thalassemia major, has significantly risen in the last decades. Cardiac morbidity-heart failure and dysrhythmias-is still the most common cause of mortality in these patients. We describe herein a case of myocardial infarction with normal coronary arteries in a 48-year-old patient with beta-thalassemia and no other recognized risk factors for coronary artery disease. Thromboembolic phenomena, a known situation in these patients, occur at a frequency of 4-5%. However, as far as we know, this is the first report in the literature of myocardial infarction in association with beta-thalassemia. With the notable improvement in the life expectancy of thalassemia patients, ischemic heart disease may become an important complication encountered in these patients.
Related Concept Videos
01:21Myocarditis I: Introduction
01:30Acute Coronary Syndrome I: Introduction
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...